Why do some Ortho companies grow and others struggle ?
The orthopedic industry is a dynamic landscape where innovation, strategy, and execution determine which companies thrive and which languish. While […]
The orthopedic industry is a dynamic landscape where innovation, strategy, and execution determine which companies thrive and which languish. While […]
Labramend is a stealth startup in orthopedics with a product design that we need to turn into an inflatable balloon.
Learn the essential strategies orthopedic startups need to transform cutting-edge technology into market success, avoiding the “Field of Dreams” trap.
I hunt for game-changers—technologies that don’t just nudge the needle but rewrite the rules. VISIE is one of those rare
Key Points Research suggests fewer ETO sterilization suppliers in the US due to stricter regulations and health concerns. It seems
Tiger’s world’s is built on helping small orthopedic companies and entrepreneurs thrive, and there is a deliberate ecosystem to make
The spine industry is buzzing with futuristic ideas—AI-crafted implants, robotic precision, and augmented reality guiding surgeons’ hands. These concepts, spotlighted
At what point did selling orthopedic products stop being about clinical value and patient outcomes—transforming entirely into a game of
Sharing with the Orthopedics world my newly created AI clone trained on thousands of orthopedic articles and conversations. Whether you
The Problem – Vague Silence. Orthopedic startups struggle to secure funding, facing a wall of silence from VCs. Pitch after
A Tale of Frozen Ambition Jim, a marketing lead at an orthopedic startup, called me. He had a vision: a
Simple. Bring on board people and consultants from large established companies—places with flawless organization, top-notch systems, and airtight processes. Done.
Learn the 4 keys to running cost-effective trials with lean data, scalable designs, smart tech, and expert partnerships. Early-stage orthopedic
Launching an ortho startup? Focus on three essentials in Year Zero: team, product, and customers. Here’s the breakdown. 1. Obsess
Key Points Research suggests Trump’s tariffs are likely impacting US-based orthopedic medical device companies, increasing costs and disrupting supply chains.
But wait there’s more. GLP-1s continue to bring miracles. The new study, “Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel
The Orthopedic cartel like Stryker, Zimmer Biomet, and Johnson & Johnson are players in a high-stakes Game Theory showdown. Stryker’s
GLP-1 drugs (e.g., Ozempic, Mounjaro), primarily used for type 2 diabetes and weight loss, can have several implications for potential
Sharing a quick example from S. Korea that has a small US office in Irvine. CG MedTech is a South
Our industry is shifting fast, and some old ways are losing ground. I am tracking a few changes to keep
Recruiting is hard work. Companies often exhaust internal efforts before turning to outside recruiters, but what do these pros actually
Think about the last time you scanned your contacts—LinkedIn, your phone, your mental “network.” How many are real? Not just
As a retained recruiter I get to work with orthopedic companies as they grow and mature. The sales needs of
Let me know and I’ll give you a specific suggestion help you with it. Click to ask Tiger Clone and
This message is addressed to company leaders. You may not realize that your company has an industry-wide reputation, not based
As predicted, the GLP-1 revolution has only accelerated, and this miracle drug will reshape the orthopedic landscape going forward. Recent
Sharing Troy Fugate’s LinkedIN posting.. FDA 483 observations require serious, well-documented corrective actions, but some companies have responded with unbelievable
Early-stage ortho companies obsess over what’s in their grasp—patents, funding, slick prototypes, quality systems, and the FDA/EU regulatory circus. This
For many emerging orthopedic device startups, the conventional path involves building a business around a sales representative-driven model. This typically
The ONLY orthopedic-related company to pursue the public markets since Monogram (2023) and Treace (2021) is HingeHealth – https://www.hingehealth.com/ On March
The LSI conference has emerged as a premier platform fostering collaboration between orthopedic startups and investors. Its success, in my
The acquisition of Amplitude Surgical by Zydus Lifesciences is highly significant for the hip and knee orthopedic industry for several
I have been writing about how simplicity is the answer, choice is a tax on everyone, and some orthopedic device
Orthofix’s fired execs’ lewd, ‘graphic’ texts surface in legal battle (MedTechDive) Orthofix didn’t originally specify the reasons behind the 2023
Broken Legs and Ankles Heal Better If You Walk on Them within Weeks (Scientific American) Using crutches for months is
Not all “AI” in orthopedics is what it seems. As you wander the halls of AAOS, “AI” buzzwords will be
We are the guilty ones. The orthopedic device industry has collectively conditioned our customers to expect unrestricted access to any
I am noticing a new trend. The sports medicine space is bubbling up with alot of potential this year, and
When evaluating early stage orthopedic companies —there’s a hidden challenge: not every founder pitching is the real deal. Marc Andreessen,
Like it or not, AI will erase the British spellings in Orthopedics forever. The British spelling “orthopaedics,” with its elegant
In the orthopedic industry’s push for innovation and differentiation, a prevailing storyline suggests that Big Ortho companies stumble due to
If you don’t know OREF, you are living in a cave. OREF was founded in 1955 by orthopedic surgeons to
Imagine if someone had visibility into ALL early orthopedic innovation. Even more specifically, if someone had early discussions with startups
Complexity isn’t just a byproduct; it’s often a strategy. The orthopedic device industry, much like credit card companies or car
In orthopedics, the term “nano” has become a buzzword, promising revolutionary changes at the smallest scales of material science. However,
I recently shared a blunt thought on LinkedIn: “I’ve come to the conclusion that everyone in orthopedics ‘says’ they want
Website – https://nanovistechnology.com/ Medtronic buys Nanovis’ nano technology for use in spine implants (MedTechDive) Medtronic will use the technology to
Recent developments at Mass General Brigham (MGB), where the health system announced the largest layoffs in its history, suggest a
Times are getting strange. I have seen a disturbing trend where some capital allocators engage in predatory practices, particularly targeting
In the vast, ever-evolving world of orthopedics, there’s a term that whispers through the halls of hospitals and clinics like